Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02145572 · ClinicalTrials.gov registry record
Metabolomic Profiling in Adolescents With Obesity and Diabetes
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 90
- Enrollment target
NCT02145572: Completed study, sponsored by University of California, San Diego.
NCT02145572 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02145572 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to identify unique metabolite signatures associated with the development of Type 2 diabetes and diabetic kidney disease in children. We have a sub-study, with the purpose to validate the presence of a genetic marker (DENND1A) in the urine of adolescent females with polycystic ovarian syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2014-05 |
| Est. Completion | 2020-07 |
What the finished NCT02145572 record still lists
NCT02145572 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02145572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02145572 about?
NCT02145572 is a clinical study titled "Metabolomic Profiling in Adolescents With Obesity and Diabetes". The purpose of this study is to identify unique metabolite signatures associated with the development of Type 2 diabetes and diabetic kidney disease in children. We have a sub-study, with the purpose to validate the presence of a genetic marker (DENND1A) in the urine of adolescent females with poly...
What is the current status of trial NCT02145572?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2014-05. Estimated completion is 2020-07.
Who is sponsoring clinical trial NCT02145572?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia